Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder
Research output: Patent
NOVELTY - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound (I) in combination with serotonin reuptake inhibitor, is used.
USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.
ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.
DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.
USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.
ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.
DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.
| Original language | English |
|---|---|
| IPC | C07D-307/79 |
| Patent number | WO2013110313-A1 |
| Country/Territory | Denmark |
| Priority date | 21/08/2013 |
| Priority number | WOEP050952 |
| Publication status | Published - 2013 |
ID: 137375992